Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status – Monthly Prescribing Reference (registration)

Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status
Monthly Prescribing Reference (registration)
The trial is intended to examine Generx as a one-time treatment for improving exercise tolerance in patients who have angina that is refractory to standard medical therapy and not amenable to conventional revascularization procedures (coronary artery ...

Read the rest here:

Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status - Monthly Prescribing Reference (registration)

Related Posts

Comments are closed.